Our findings demonstrate that TCF3 directly interacts with TMBIM6 and transcriptionally upregulates its expression, thereby mediating Ca2+-dependent ferroptosis resistance and facilitating bladder cancer progression. Here, TCF3 is linked to urinary bladder carcinoma.